|
|
|
| Contamination control is evolving from a compliance checklist to a comprehensive, risk-based strategy for sterile drug manufacturing. Emerging USP draft chapters <1110> and <1114> align with EU GMP Annex 1 by emphasizing holistic contamination control, continuous verification, and scientific risk management. Although not yet official, these guidelines signal future regulatory expectations. Manufacturers that proactively strengthen contamination control strategies now will be better positioned to meet global requirements, protect product quality, and safeguard patient safety. Learn more |
|
|
|
|
In this Live event segment, panelist Dominick DeGrazio discusses alignment of formulations with delivery devices. He points to key determiners including Target Product Profile (TPP), preferred dosage form, and using platform technologies versus assessing new device options. |
|
|
The Hidden Operational Complexities Of Home Infusion | By Chris Van Raam, PharmD, MBA, chief operating officer, ContinuumRx, an Acelpa Health company and Erica Blanchard, PharmD, vice president of pharmacy operations, California Specialty Pharmacy, an Acelpa Health company | Home infusion can lower costs and improve access, but requires complex coordination, patient readiness, logistics, and monitoring to ensure safe and effective care. |
|
|
|
|
| The Impact Of PEGs In The Small Molecule API Market | Webinar | MilliporeSigma | Explore how PEG selection shapes drug development success by understanding the benefits of expert CDMO partnerships that deliver custom solutions to enhance your small molecule program. |
|
|
|
|
| Device Design For Usability And Risk Reduction | Article | Dr. Sylvine Raverdy-Wilson, BD Medical - Pharmaceutical Systems | Growing use of large‑volume subcutaneous therapies is increasing demand for wearable injectors that reduce user error, simplify preparation, and enhance safety through human‑factors‑focused design. |
|
|
| Advancing Chronic Care Through GLP‑1 Innovation | White Paper | Kindeva | GLP‑1 therapies are changing injectable care and driving rapid progress in delivery and manufacturing. See how patient needs, emerging tech, and regulations are reshaping chronic treatment. |
|
|
|
|
|
.png){kind=logo}
